Search

Your search keyword '"Darazam, Ilad Alavi"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Darazam, Ilad Alavi" Remove constraint Author: "Darazam, Ilad Alavi"
216 results on '"Darazam, Ilad Alavi"'

Search Results

1. Large Language Models versus Classical Machine Learning: Performance in COVID-19 Mortality Prediction Using High-Dimensional Tabular Data

3. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

4. Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study

7. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study

10. Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID–IRI study

13. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey

14. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study.

15. Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial

18. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021)

19. Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial

23. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species–induced meningoencephalitis, colitis, or both

25. Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency

27. Garcin syndrome in a case of acquired immunodeficiency syndrome

29. Meta-analysis of Macrolide Resistance Pattern of Mycoplasma pneumoniae in the World

30. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey

32. Antimicrobial Resistance Pattern of Moraxella catarrhalis and Haemophilus influenza in Iran; a Systematic review

33. Antibiotic use during the first 6 months of COVID ‐19 pandemic in Iran: A large‐scale multi‐centre study

34. A Case of Fingolimod-associated Cryptococcal Meningitis

35. Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey

36. Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency

40. Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency

41. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

42. Clinical Aspects, Microbiological Features, and Therapeutic Outcome of Brain Abscess: An Experience of a Referral Center

43. Chronic necrotizing granulomatous skin lesions and MHC class I deficiency syndrome due to TAP2 deficiency

44. Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series

45. Lupus Anticoagulant Is Associated with Critical Cases and High Mortality in COVID-19: A Literature Review.

46. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

47. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

48. X-linked recessive TLR7 deficiency in similar to 1% of men under 60 years old with life-threatening COVID-19

49. Association between serum inflammatory parameters and the disease severity in COVID‐19 patients

50. Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial

Catalog

Books, media, physical & digital resources